Lenagen-25

Packed:	25 mg / 30 Capsules
Manufacturer:	Hetero Labs Limited Manufactured by Hetero Labs Distributed by Genygi Life
Active ingredient:	Lenalidomide Capsules IP 25 mg

Lenagen-25 mg – for the treatment of adult patients with previously untreated multiple myeloma who are not candidates for hematopoietic stem cell transplantation.

In combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one line of therapy.

Download Documentation

Disclaimer:

This medical information is intended exclusively for healthcare professionals in India. The products discussed herein may have different labeling and regulatory requirements in other countries.

The information provided on this site is scientific, evidence-based, and intended to address unsolicited medical inquiries in a balanced manner.

For full Prescribing Information, including indications, contraindications, warnings, precautions, and potential adverse events, please submit a medical information request.

This content is not intended as medical advice. Responsibility for patient care rests solely with the healthcare professional, based on their professional license, expertise, and knowledge of the patient.

This website does not engage in the sale or purchase of any medicines.

Lenagen-25

Gefigen-250

Genzibo-40

Imatigen-100

Lenvagen-10

Pazogen-200

Pomagen-2

Sunitigen-50

Tamoxelle 20

Genygi Life Sciences Private Limited

Lenagen-25

Related products

Genygi Life Sciences Private Limited